Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Quarterly results
Appointed COO
Appointed director
|
|
HUMANIGEN, INC (HGEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/14/2022 |
8-K
| Quarterly results |
| 08/12/2022 |
8-K
| Quarterly results |
| 05/05/2022 |
8-K
| Quarterly results |
| 11/12/2021 |
8-K
| Quarterly results |
| 08/12/2021 |
8-K
| Quarterly results |
| 05/13/2021 |
8-K
| Quarterly results |
| 11/12/2020 |
8-K
| Quarterly results |
| 08/07/2014 |
8-K
| Quarterly results |
| 11/12/2013 |
8-K
| Form 8-K - Current report |
| 05/14/2013 |
8-K
| Quarterly results|
Docs:
|
"Consolidated Balance Sheets March 31, 2013 and December 31, 2012 March 31, 2013 December 31, 2012 Assets Current assets: Cash and cash equivalents $ 69,949 $ 10,947 Marketable securities 6,901 9,351 Contract receivables 34 87 Prepaid expenses and other current assets 1,896 871 Total current assets 78,780 21,256 Restricted cash 205 205 Property and equipment, net 193 230 Deferred offering costs — 2,803 Intangible and other assets 41 45 Total assets $ 79,219 $ 24,539 Liabilities, convertible preferred stock and stockholders' equity Current liabilities: Accounts payable $ 6,199 $ 2,448 Accrued compensation 828 628 Deferred rent, short-term 113 101 Accrued research and clinical liabilities 1,384 3,538 Notes Payable 811 — Other accrued liabilities 275 502 Total current liabilities 9,610 7,217 D..." |
|
|
|